Phase II Randomized Trial to Evaluate Two Strategies: Continuing Versus Intermittent (Drug-holiday) Trabectedin-regimen in Patients With Advanced Soft Tissue Sarcoma Experiencing Response or Stable Disease After the Sixth Cycle.
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2018
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 05 Oct 2016 According to PharmaMar media release, update/data of this trial will be presented at ESMO congress 2016.
- 10 Feb 2015 Status changed from active, no longer recruiting to completed, according to results published in the Lancet Oncology.